EUVIMEDEUVIMED entdecken
Crossref

PRIORITIZE study: Prioritizing Resumption Of Colorectal screening after covid pandemic

S. Pecere, L. Frazzoni, C. Hassan, L. E. Del Vecchio, C. Fabbri, F. Iacopini, A. Repici, C. Spada, C. Senore, A. Giulio, L. Fuccio

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S469-S470

DOI: 10.1055/s-0044-1783889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von S. Pecere und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

FIT-based colorectal cancer screening programs have been severely hampered during COVID-19 pandemic and its aftermath. Both test distribution and post-FIT colonoscopies have seen a manifold decrease in number of performed procedures. It is well known that any delay in post-FIT+colonoscopy results in an increase in advanced neoplasia and CRC. Since colonoscopy slots are limited, any means to risk-stratify subjects before post-FIT colonoscopy may result in timely diagnosis of CRC and advanced adenomas, but such tools are currently lacking. Aim of our study was to develop and validate a simple scoring system to effectively sub-stratify CRC/advanced adenomas risks in FIT+patients, based on the retrospective analysis of a large cohort of patients in a long-standing FIT based CRC screening program.

Methods

This was a retrospective analysis of prospectively collected data from a regional CRC screening program in Italy, from 2004 to 2019. Men and women aged 58 to 70 years were invited to undergo quantitative FIT (OC-sensor FIT) and subsequent colonoscopy if≥20 µg Hb/g of feces (FIT+). Patients who underwent both FIT test with positive results and colonoscopy were included in the study. A multivariable logistic regression analysis was performed to identify variables independently associated to CRC and advanced adenoma risks in the derivation cohort (2004-2015), and the discriminative performance of the model was tested on the validation cohort (2016-2019).

Results

Overall, 40,640 patients undergoing colonoscopy after a FIT+, were included. Prevalence of first-round FIT+subjects was 58.5%. Median FIT was 52.4 mcg/g (IQR, 29.8-137.3). CRC was found in 2,164 (5.4%) subjects, high-risk adenomas in 12,218 (30.3%), and low-risk adenomas in 5,990 (14.9%). Variables independently associated with CRC were age≥70 years (OR 1.20, 95% CI 1.03-1.40), male sex (OR 1.23, 95% CI 1.11-1.37), FIT≥50 mcg/g and

Zitieren

APA

Pecere, S., Frazzoni, L., Hassan, C., Vecchio, L. E. D., Fabbri, C., Iacopini, F., Repici, A., Spada, C., Senore, C., Giulio, A., & Fuccio, L. (2024). PRIORITIZE study: Prioritizing Resumption Of Colorectal screening after covid pandemic. Endoscopy, 56(S 02 S 02), S469-S470. https://doi.org/10.1055/s-0044-1783889

Vancouver

Pecere S, Frazzoni L, Hassan C, Vecchio LED, Fabbri C, Iacopini F, et al. PRIORITIZE study: Prioritizing Resumption Of Colorectal screening after covid pandemic. Endoscopy. 2024;56(S 02 S 02):S469-S470. doi:10.1055/s-0044-1783889

BibTeX
@article{Pecere2024,
  author = {Pecere, S. and Frazzoni, L. and Hassan, C. and Vecchio, L. E. Del and Fabbri, C. and Iacopini, F. and Repici, A. and Spada, C. and Senore, C. and Giulio, A. and Fuccio, L.},
  title = {PRIORITIZE study: Prioritizing Resumption Of Colorectal screening after covid pandemic},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S469--S470},
  doi = {10.1055/s-0044-1783889}
}
Kostenlos starten →